Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma?

by Young, Ken H.
Published in Cancer Commun (Lond) (2021)

Age cutoff in lymphoma diagnosis

by Ok, Chi Y., Young, Ken H.
Published in Aging (Albany NY) (2015)

Checkpoint inhibitors in hematological malignancies

by Ok, Chi Young, Young, Ken H.
Published in J Hematol Oncol (2017)

Targeting the Programmed Death-1 Pathway in Lymphoid Neoplasms

by Ok, Chi Young, Young, Ken H.
Published in Cancer Treat Rev (2017)

The TP53 tumor suppressor and autophagy in malignant lymphoma

by Xu-Monette, Zijun Y., Young, Ken H.
Published 2012

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders

by Cai, Qingqing, Chen, Kailin, Young, Ken H
Published in Exp Mol Med (2015)

The PTEN tumor suppressor gene and its role in lymphoma pathogenesis

by Wang, Xiaoxiao, Huang, Huiqiang, Young, Ken H.
Published in Aging (Albany NY) (2015)

Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies

by Sun, Ruifang, Wang, Jinfen, Young, Ken H.
Published in Crit Rev Oncog (2017)

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment()

by Cai, Qingqing, Fang, Yu, Young, Ken H.
Published in Transl Oncol (2019)

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

by Ok, Chi Young, Li, Ling, Young, Ken H
Published in Exp Mol Med (2015)

Signaling Pathway and Dysregulation of PD1 and its Ligands in Lymphoid Malignancies

by Xia, Yi, Medeiros, L. Jeffrey, Young, Ken H.
Published in Biochim Biophys Acta (2015)

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma

by Zhang, Jun, Medeiros, L. Jeffrey, Young, Ken H.
Published in Front Oncol (2018)

Cross-talk between Myc and p53 in B-cell lymphomas

by Yu, Li, Yu, Tian-Tian, Young, Ken H.
Published in Chronic Dis Transl Med (2019)

New agents and regimens for diffuse large B cell lymphoma

by Wang, Liang, Li, Lin-rong, Young, Ken H.
Published in J Hematol Oncol (2020)

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas

by Xu-Monette, Zijun Y., Zhou, Jianfeng, Young, Ken H.
Published in Blood (2018)

Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies

by Sun, Rui-Fang, Yu, Qian-Qian, Young, Ken H.
Published in Chronic Dis Transl Med (2018)

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma

by Cai, Qingqing, Cai, Jun, Fang, Yu, Young, Ken H.
Published in Front Oncol (2019)

Fulminant EBV-driven CD8 T-cell Lymphoproliferative Disorder Following Primary Acute EBV Infection: A Unique Spectrum of T-Cell Malignancy

by Young, Ken H, Zhang, Dahua, Malik, Jeffery T, Williams, Eliot C
Published 2008

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management

by Cai, Qingqing, Medeiros, L. Jeffrey, Xu, Xiaolu, Young, Ken H.
Published in Oncotarget (2015)

NF-κB Signaling Pathway and its Potential as a Target for Therapy in Lymphoid Neoplasms

by Yu, Li, Li, Ling, Medeiros, L. Jeffrey, Young, Ken H.
Published in Blood Rev (2016)